Clinical Trials

Atomoxetine in Veterans With Comorbid ADHD/PTSD

Conditions:   Post Traumatic Stress Disorder;   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine 80 MG
Sponsor:   VA Office of Research and Development
Completed
Mon, 10 Nov 2014 12:00:00 EST

Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)

Conditions:   Memory Disorders;   Multiple Sclerosis
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Icahn School of Medicine at Mount Sinai
Completed
Mon, 27 Mar 2017 12:00:00 EDT

Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine

Condition:   Alcohol Use Disorder
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Not yet recruiting
Fri, 25 Sep 2020 12:00:00 EDT

Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia

Condition:   Schizophrenia
Intervention:   Drug: Atomoxetine
Sponsors:   Research Foundation for Mental Hygiene, Inc.;   Eli Lilly and Company
Completed
Wed, 20 Jun 2007 12:00:00 EDT

Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls

Conditions:   Continuous Methamphetamine Dependence;   Methamphetamine Dependence in Remission
Interventions:   Drug: Atomoxetine;   Other: Placebo
Sponsor:   University of California, Los Angeles
Completed
Tue, 17 Dec 2013 12:00:00 EST

Safety Assessment of Atomoxetine With MA IV Administration

Conditions:   Methamphetamine Abuse;   Methamphetamine Dependence
Interventions:   Drug: Atomoxetine, then Placebo;   Drug: Placebo, then Atomoxetine
Sponsors:   University of California, Los Angeles;   National Institute on Drug Abuse (NIDA)
Terminated
Wed, 25 Nov 2009 12:00:00 EST

Prevention of Syncope Trial 6 - Atomoxetine in Vasovagal Syncope

Condition:   Vasovagal Syncope
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   University of Calgary;   Cardiac Arrhythmia Network of Canada
Completed
Thu, 16 Jul 2015 12:00:00 EDT

Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD

Conditions:   Fetal Alcohol Syndrome;   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:   Drug: Atomoxetine
Sponsors:   University of Oklahoma;   Mark L. Wolraich
Completed
Thu, 04 Jan 2007 12:00:00 EST

Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH

Condition:   Neurogenic Orthostatic Hypotension
Interventions:   Drug: Midodrine;   Drug: Atomoxetine
Sponsors:   Seoul National University Hospital;   Kyung Hee University Hospital at Gangdong
Completed
Wed, 22 Nov 2017 12:00:00 EST

Bariatric Surgery and Pharmacokinetics of Atomoxetine

Condition:   Obesity, Morbid
Intervention:   Drug: Atomoxetine
Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Volvat Medisinsk Senter Stokkan;   Namsos Hospital;   Alesund Hospital
Recruiting
Fri, 09 Mar 2018 12:00:00 EST

A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Wed, 09 May 2007 12:00:00 EDT

Cognitive Effects of Atomoxetine in Humans: Genetic Moderators

Condition:   Addiction
Interventions:   Drug: Atomoxetine;   Drug: Sugar Pill
Sponsor:   Yale University
Completed
Fri, 23 Dec 2011 12:00:00 EST

Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)

Condition:   ADHD NOS
Intervention:   Drug: Strattera (atomoxetine)
Sponsors:   Massachusetts General Hospital;   Eli Lilly and Company
Completed
Fri, 16 Sep 2005 12:00:00 EDT

Long-Term, Open Label Atomoxetine Study

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

Conditions:   Attention Deficit Hyperactivity Disorder;   Dyslexia
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Wed, 06 Feb 2008 12:00:00 EST

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Conditions:   Fetal Alcohol Syndrome;   Attention Deficit Disorder With Hyperactivity (ADHD);   Attention Deficit Disorder (ADD)
Interventions:   Drug: Strattera;   Drug: Placebo
Sponsors:   University of Oklahoma;   Mark L. Wolraich, M.D.;   Eli Lilly and Company
Completed
Thu, 04 Jan 2007 12:00:00 EST

Post-stroke Neural Plasticity With Atomoxetine

Conditions:   Atomoxetine Hydrochloride;   Placebos
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Lumy Sawaki
Completed
Thu, 02 Jun 2016 12:00:00 EDT

Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)

Condition:   Traumatic Brain INjury
Interventions:   Drug: atomoxetine;   Drug: placebo
Sponsor:   Craig Hospital
Completed
Fri, 20 Jun 2008 12:00:00 EDT

Effects of Atomoxetine on Brain Activation During Attention & Reading Tasks in Participants With ADHD & Comorbid Dyslexia

Conditions:   Attention Deficit Hyperactivity Disorder;   Dyslexia
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Wed, 16 Jul 2008 12:00:00 EDT

A Randomized, Double-Blind Comparison of Placebo and Atomoxetine Hydrochloride Given Once a Day in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine Hydrochloride;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate;   Drug: Atomoxetine
Sponsor:   National Taiwan University Hospital
Not yet recruiting
Fri, 03 May 2019 12:00:00 EDT

Atomoxetine and Oxybutynin in Obstructive Sleep Apnea

Condition:   Obstructive Sleep Apnea (OSA)
Interventions:   Drug: Combination product of Atomoxetine and Oxybutynin;   Drug: Placebo, 2 tablets
Sponsor:   Brigham and Women's Hospital
Completed
Wed, 21 Sep 2016 12:00:00 EDT

Comparison of Atomoxetine Versus Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Fri, 19 Oct 2007 12:00:00 EDT

Atomoxetine Treatment for Cognitive Impairment in Parkinson's Disease (ATM-Cog)

Conditions:   Parkinson's Disease;   Cognitive Impairment
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Medical University of South Carolina;   Michael J. Fox Foundation for Parkinson's Research
Completed
Fri, 30 Nov 2012 12:00:00 EST

Effects of Atomoxetine in Mild Cognitive Impairment

Condition:   Mild Cognitive Impairment
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Emory University;   National Institute on Aging (NIA)
Completed
Tue, 31 Jan 2012 12:00:00 EST

Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism

Condition:   Autism
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Massachusetts General Hospital;   National Institute of Mental Health (NIMH)
Completed
Mon, 09 Jul 2007 12:00:00 EDT

Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Fri, 14 Mar 2008 12:00:00 EDT

Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE

Conditions:   Attention Deficit Hyperactivity Disorder;   Cannabis Abuse
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Terminated
Mon, 02 Jun 2008 12:00:00 EDT

Atomoxetine Phase 2 Study in Japanese Adult Patients With Attention Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Mon, 17 Sep 2007 12:00:00 EDT

Atomoxetine and Huntington's Disease

Conditions:   Huntington Disease;   Chorea
Interventions:   Drug: atomoxetine;   Drug: Matching Placebo
Sponsors:   University of Iowa;   Eli Lilly and Company
Completed
Tue, 29 Aug 2006 12:00:00 EDT

Driving in Adults With Attention-deficit/Hyperactivity Disorder (ADHD) Before and During Treatment With Atomoxetine

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsors:   Central Institute of Mental Health, Mannheim;   Heidelberg University
Completed
Tue, 14 Jul 2009 12:00:00 EDT

Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

Conditions:   ADHD;   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine and OROS Methylphenidate
Sponsors:   Massachusetts General Hospital;   Ortho-McNeil Janssen Scientific Affairs, LLC
Completed
Fri, 04 Jan 2008 12:00:00 EST

Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Fri, 26 Sep 2008 12:00:00 EDT

Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine hydrochloride
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Conditions:   Autistic Disorder;   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Tue, 26 Sep 2006 12:00:00 EDT

Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsors:   NYU Langone Health;   Eli Lilly and Company
Completed
Thu, 06 Aug 2009 12:00:00 EDT

Clinical Efficacy of Atomoxetine for Methamphetamine Dependence

Condition:   Methamphetamine Dependence
Interventions:   Drug: Atomoxetine;   Drug: placebo
Sponsors:   University of Arkansas;   National Institute on Drug Abuse (NIDA)
Completed
Mon, 19 Mar 2012 12:00:00 EDT

Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine Hydrochloride;   Drug: placebo
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Comparison of Atomoxetine and Placebo in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and/or Reading Disorder (RD)

Conditions:   Attention Deficit Hyperactivity Disorder;   Reading Disorder
Interventions:   Drug: Atomoxetine Hydrochloride;   Drug: placebo
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers

Condition:   Nicotine Dependence
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Yale University;   VA Office of Research and Development
Withdrawn
Mon, 27 Jan 2014 12:00:00 EST

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Condition:   Attention-Deficit/Hyperactivity Disorder
Interventions:   Drug: Lisdexamfetamine Dimesylate;   Drug: Atomoxetine Hydrochloride
Sponsor:   Shire
Completed
Mon, 19 Apr 2010 12:00:00 EDT

Atomoxetine for the Treatment of Cannabis Dependence

Condition:   Cannabis Dependence
Intervention:   Drug: Atomoxetine
Sponsors:   National Institute on Drug Abuse (NIDA);   University of Pennsylvania
Completed
Wed, 14 Sep 2005 12:00:00 EDT

Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany

Conditions:   Attention Deficit Hyperactivity Disorder;   Oppositional Defiant Disorder
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Mon, 04 Dec 2006 12:00:00 EST

Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine Hydrochloride;   Drug: Atomoxetine hydrochloride
Sponsor:   Eli Lilly and Company
Completed
Thu, 06 Dec 2007 12:00:00 EST

Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: OROS MPH;   Drug: Atomoxetine
Sponsor:   Peking University
Completed
Tue, 09 Feb 2010 12:00:00 EST

Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder

Condition:   Generalized Social Phobia
Interventions:   Drug: atomoxetine;   Drug: placebo
Sponsors:   University of California, San Diego;   Eli Lilly and Company
Completed
Thu, 01 Dec 2005 12:00:00 EST

Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder

Conditions:   Attention Deficit Hyperactivity Disorder;   Substance Abuse
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Denver Health and Hospital Authority;   American Academy of Child Adolescent Psychiatry.
Completed
Wed, 15 Nov 2006 12:00:00 EST

Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Wed, 19 Aug 2009 12:00:00 EDT

Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:   Drug: atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Wed, 03 May 2006 12:00:00 EDT

An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD).

Conditions:   Attention Deficit Hyperactivity Disorder;   Oppositional Defiant Disorder
Interventions:   Drug: atomoxetine 0.5 mg/kg/day;   Drug: placebo;   Drug: atomoxetine 1.2 mg/kg/day;   Drug: atomoxetine 1.2-1.4 mg/kg/day
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

Conditions:   Menopause;   Cognitive Disturbances
Interventions:   Drug: atomoxetine;   Drug: placebo
Sponsors:   University of Pennsylvania;   Eli Lilly and Company
Completed
Mon, 11 Feb 2008 12:00:00 EST

Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: atomoxetine
Sponsor:   Peking University
Unknown status
Wed, 20 Apr 2011 12:00:00 EDT

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine hydrochloride;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Wed, 01 Aug 2007 12:00:00 EDT

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Conditions:   Schizophrenia;   Memory Disorders;   Cognition Disorders
Interventions:   Drug: Atomoxetine;   Procedure: Functional magnetic resonance imaging;   Procedure: Neuropsychological Testing;   Drug: Placebo
Sponsor:   National Institute of Mental Health (NIMH)
Terminated
Tue, 23 Oct 2007 12:00:00 EDT

A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine;   Drug: Other standard therapy for ADHD
Sponsor:   Eli Lilly and Company
Completed
Wed, 14 Mar 2007 12:00:00 EDT

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Conditions:   Attention Deficit Disorder With Hyperactivity;   Cocaine-Related Disorders
Intervention:   Drug: Atomoxetine
Sponsors:   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA)
Completed
Thu, 22 Sep 2005 12:00:00 EDT

Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia

Conditions:   Opiate Dependence;   Stimulant Dependence
Intervention:   Drug: Atomoxetine
Sponsor:   Yale University
Completed
Mon, 27 May 2013 12:00:00 EDT

A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Tue, 01 Sep 2009 12:00:00 EDT

A Bioequivalence (BE) Study in Healthy Subjects

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsor:   Eli Lilly and Company
Completed
Mon, 09 Aug 2010 12:00:00 EDT

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

Conditions:   Attention Deficit Hyperactivity Disorder;   Oppositional Defiant Disorder
Interventions:   Drug: atomoxetine hydrochloride;   Drug: placebo
Sponsor:   Eli Lilly and Company
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Atomoxetine Effects in Humans

Condition:   Physiological Stress
Intervention:   Drug: Atomoxetine
Sponsors:   Yale University;   National Institute on Drug Abuse (NIDA)
Completed
Tue, 05 Feb 2008 12:00:00 EST

A Dose Response Effect of Atomoxetine to the Acute Effects of Alcohol

Conditions:   Alcohol Craving;   Mood Changes
Intervention:   Drug: Atomoxetine, Strattera
Sponsors:   University of Colorado, Boulder;   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Center for Research Resources (NCRR)
Terminated
Wed, 03 Aug 2011 12:00:00 EDT

Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Drug: Sugar Pill
Sponsors:   University of Cincinnati;   National Institute of Mental Health (NIMH)
Unknown status
Thu, 07 Apr 2011 12:00:00 EDT

A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment

Conditions:   Cocaine Dependence;   Opiate Dependence
Interventions:   Drug: Atomoxetine, low dose;   Drug: Atomoxetine, high dose;   Drug: Placebo
Sponsor:   Yale University
Terminated
Fri, 01 Mar 2013 12:00:00 EST

Atomoxetine in Patients With Tourette's Syndrome

Condition:   Tourette Syndrome
Intervention:   Drug: Atomoxetine
Sponsor:   Poitiers University Hospital
Not yet recruiting
Tue, 21 Apr 2020 12:00:00 EDT

Atomoxetine for Treating Marijuana-Abusing Adolescents Who Have Attention Deficit Hyperactivity Disorder

Conditions:   Attention Deficit Disorder With Hyperactivity;   Marijuana Abuse
Interventions:   Drug: Atomoxetine;   Other: placebo
Sponsors:   New York State Psychiatric Institute;   National Institute on Drug Abuse (NIDA)
Completed
Fri, 02 Sep 2005 12:00:00 EDT

Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHD

Condition:   ADHD
Interventions:   Drug: Mixed amphetamine salts (ADDERALL XR);   Drug: Atomoxetine hydrochloride
Sponsor:   Shire
Completed
Wed, 25 Jul 2007 12:00:00 EDT

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Conditions:   Cerebrovascular Accident;   Transient Ischemic Attack;   ADHD
Interventions:   Drug: atomoxetine;   Drug: Stimulants;   Other: No intervention (general population)
Sponsors:   Eli Lilly and Company;   i3 Drug Safety
Completed
Thu, 13 Mar 2008 12:00:00 EDT

Treatment of Executive Dysfunction in Parkinson's Disease

Condition:   Parkinson's Disease
Intervention:   Drug: Atomoxetine
Sponsors:   Johns Hopkins University;   Eli Lilly and Company
Completed
Mon, 06 Feb 2006 12:00:00 EST

Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young Children

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Drug: Placebo;   Behavioral: Parent Training
Sponsors:   University of Nebraska;   National Institute of Mental Health (NIMH)
Completed
Wed, 16 Nov 2005 12:00:00 EST

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine

Condition:   Type 1 Diabetes
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   University of Maryland, Baltimore;   National Heart, Lung, and Blood Institute (NHLBI)
Completed
Mon, 27 Oct 2008 12:00:00 EDT

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: atomoxetine hydrochloride;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Completed
Wed, 18 Jun 2008 12:00:00 EDT

The Effect of a Once Daily Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents

Conditions:   Attention Deficit Hyperactivity Disorder;   Insomnia
Interventions:   Drug: atomoxetine;   Drug: placebo
Sponsor:   Rhode Island Hospital
Completed
Mon, 03 Dec 2007 12:00:00 EST

Atomoxetine PBPK-PD Clinical Study

Condition:   ADHD
Intervention:   Drug: Atomoxetine Hydrochloride
Sponsors:   Children's Mercy Hospital Kansas City;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
Tue, 16 May 2017 12:00:00 EDT

Impact of Strattera and Behavior Therapy on the Home and School Functioning of Children With ADHD

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: atomoxetine;   Behavioral: Behavior Modification Therapy
Sponsors:   State University of New York at Buffalo;   Eli Lilly and Company
Completed
Thu, 11 Jun 2009 12:00:00 EDT

A Study in Attention Deficit Hyperactivity Disorder in Children and Adolescents

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine;   Drug: Osmotic-release oral system methylphenidate;   Drug: Placebo
Sponsor:   Eli Lilly and Company
Terminated
Fri, 21 May 2010 12:00:00 EDT

Effects of Atomoxetine Treatment in Humans

Condition:   Stress
Interventions:   Drug: Placebo;   Drug: Atomoxetine
Sponsors:   Yale University;   US Department of Veterans Affairs
Completed
Mon, 11 Feb 2008 12:00:00 EST

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

Conditions:   Obstructive Sleep Apnea;   Hypertension
Interventions:   Drug: AD113;   Drug: Atomoxetine
Sponsor:   Apnimed
Recruiting
Fri, 28 May 2021 12:00:00 EDT

Atomoxetine for Children With Acquired Attentional Disorders Following Completion of Chemotherapy for ALL

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsors:   Monarch Medical Research;   Eli Lilly and Company
Terminated
Mon, 06 Mar 2006 12:00:00 EST

Atomoxetine Treatment for ADHD and Marijuana Dependence

Conditions:   Marijuana Abuse;   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Procedure: Motivational enhancement therapy;   Drug: Placebo
Sponsors:   Medical University of South Carolina;   National Institute on Drug Abuse (NIDA)
Completed
Fri, 04 Aug 2006 12:00:00 EDT

Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation

Condition:   Cognition in Schizophrenia
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   University of Texas Southwestern Medical Center;   National Institute of Mental Health (NIMH);   Stanley Medical Research Institute
Completed
Wed, 05 Mar 2008 12:00:00 EST

Atomoxetine, Diurnal Profiles of Cortisol and α-amylase

Condition:   ADHD
Interventions:   Drug: Medication Other;   Device: motor measurement and saliva collection
Sponsors:   Praxis für kleine und grosse Leute;   Dr med Kurt von Siebenthal, Facharztpraxis für Pädiatrie, Winterthur, Switzerland;   Dr med Roland Kägi, Facharztpraxis für Pädiatrie, Zurich, Switzerland;   Dr med Corrado Garbazza, University of Basle, Switzerland;   Prof Vivette Glover, Imperial College London, UK;   Prof Alina Rodriguez, University of Lincoln, UK
Unknown status
Thu, 09 Mar 2017 12:00:00 EST

Effects of Atx and Oros-mph on Executive Functions

Condition:   Executive Dysfunction
Interventions:   Drug: Atomoxetine;   Drug: methylphenidate
Sponsor:   TC Erciyes University
Completed
Mon, 02 Feb 2015 12:00:00 EST

Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD

Conditions:   Attention Deficit Hyperactivity Disorder;   Substance Use Disorder
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Institute on Drug Abuse (NIDA)
Withdrawn
Thu, 23 Sep 2010 12:00:00 EDT

Orthostatic Intolerance After Bariatric Surgery

Condition:   Orthostatic Intolerance
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Vanderbilt University Medical Center
Active, not recruiting
Fri, 18 Jan 2019 12:00:00 EST

Efficacy of Atomoxetine Therapy Versus Placebo for Cognitive Late Effects

Conditions:   Cancer;   Cognitive Late Effects
Intervention:   Drug: Atomoxetine
Sponsors:   Temple University;   Eli Lilly and Company
Withdrawn
Thu, 17 Nov 2005 12:00:00 EST

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

Condition:   Neurogenic Orthostatic Hypotension
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   Vanderbilt University Medical Center;   NYU Langone Health
Active, not recruiting
Fri, 27 May 2016 12:00:00 EDT

Strattera Treatment in Children With ADHD Who Have Poor Response to Stimulant Therapy

Condition:   ADHD
Intervention:   Drug: atomoxetine (Strattera)
Sponsors:   Massachusetts General Hospital;   Eli Lilly and Company
Completed
Fri, 16 Sep 2005 12:00:00 EDT

TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Condition:   Parkinson's Disease, Idiopathic
Interventions:   Drug: Methylphenidate;   Other: Physical Therapy;   Drug: Atomoxetine
Sponsor:   Hubert Fernandez
Recruiting
Thu, 25 Aug 2016 12:00:00 EDT

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

Condition:   Substance Abuse
Interventions:   Drug: atomoxetine;   Drug: placebo
Sponsors:   Sharon Walsh;   Eli Lilly and Company;   National Institute on Drug Abuse (NIDA)
Completed
Fri, 15 Feb 2008 12:00:00 EST

Medications for Obstructive Sleep Apnea In Children With Down Syndrome

Conditions:   Obstructive Sleep Apnea;   Down Syndrome
Intervention:   Drug: Atomoxetine and oxybutynin (ato-oxy)
Sponsors:   University of Arizona;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting
Fri, 04 Oct 2019 12:00:00 EDT

Atomoxetine, Placebo and Parent Management Training in Autism

Conditions:   Autism;   Pervasive Development Disorder;   Asperger's Disorder;   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: atomoxetine;   Drug: Placebo;   Behavioral: Parent Management Training
Sponsors:   University of Rochester;   University of Pittsburgh;   Ohio State University
Completed
Mon, 16 Feb 2009 12:00:00 EST

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Mixed salts of a single-entity amphetamine;   Drug: Atomoxetine hydrochloride
Sponsor:   Shire
Completed
Wed, 14 Nov 2007 12:00:00 EST

Atomoxetine in the Treatment of Binge Eating Disorder

Condition:   Binge-eating Disorder
Intervention:   Drug: atomoxetine
Sponsors:   Lindner Center of HOPE;   University of Cincinnati
Completed
Fri, 19 May 2006 12:00:00 EDT

A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia

Conditions:   Schizophrenia;   Schizoaffective Disorder
Intervention:   Drug: Atomoxetine (Strattera)
Sponsors:   University of Pittsburgh;   Stanley Medical Research Institute
Completed
Thu, 22 Sep 2005 12:00:00 EDT

Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

Condition:   Schizophrenia
Intervention:   Drug: Atomoxetine
Sponsor:   University of Maryland, Baltimore
Completed
Mon, 12 Sep 2005 12:00:00 EDT

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Drug: Methylphenidate
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Institute of Mental Health (NIMH)
Completed
Fri, 16 Sep 2005 12:00:00 EDT

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Condition:   Cocaine-Related Disorders
Intervention:   Drug: Atomoxetine
Sponsor:   National Institute on Drug Abuse (NIDA)
Completed
Wed, 14 Dec 2005 12:00:00 EST

A Novel Pharmacological Therapy for Obstructive Sleep Apnea

Condition:   Sleep Apnea
Interventions:   Drug: Atomoxetine;   Drug: Oxybutynin;   Drug: Placebo
Sponsor:   Brigham and Women's Hospital
Recruiting
Thu, 18 Apr 2019 12:00:00 EDT

Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia

Condition:   Schizophrenia
Intervention:   Drug: Clozapine augmented with atomoxetine up to 40 mg or placebo
Sponsors:   Indiana University School of Medicine;   Hoffmann-La Roche;   Shekhar, Anantha M.D., Ph.D.
Terminated
Thu, 22 Sep 2005 12:00:00 EDT

Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD

Condition:   ADHD
Interventions:   Drug: Atomoxetine;   Drug: Placebos
Sponsor:   RWTH Aachen University
Completed
Fri, 07 Sep 2018 12:00:00 EDT

Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers

Condition:   Attention-deficit/Hyperactivity Disorder
Interventions:   Drug: methylphenidate;   Drug: atomoxetine
Sponsor:   Seoul National University Childrens Hospital
Unknown status
Mon, 07 Dec 2015 12:00:00 EST

Community-based Study Comparing Extended-release Methylphenidate and Atomoxetine in Children With Attention-deficit Hyperactivity Disorder

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Methylphenidate extended-release; Atomoxetine
Sponsor:   McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Completed
Mon, 23 Mar 2009 12:00:00 EDT

A Gene by Medication Interaction to the Acute Effects of Alcohol

Conditions:   Alcohol-induced Cue-craving;   Alcohol Sensitivity
Interventions:   Drug: Placebo Comparator;   Drug: Active Comparator: Atomoxetine, Placebo
Sponsors:   University of Virginia;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Terminated
Thu, 28 Apr 2011 12:00:00 EDT

Treatment Compliance in Children and Adolescents on ADHD Medication

Condition:   ADHD
Interventions:   Drug: Atomoxetine;   Drug: stimulants (any approved ADHD medication)
Sponsor:   Eli Lilly and Company
Completed
Mon, 08 Oct 2007 12:00:00 EDT

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Conditions:   Attention Deficit Disorder With Hyperactivity;   Substance-Related Disorders
Interventions:   Drug: Atomoxetine hydrochloride;   Drug: Placebo
Sponsors:   Massachusetts General Hospital;   National Institute on Drug Abuse (NIDA)
Completed
Thu, 22 Sep 2005 12:00:00 EDT

Atomoxetine for Freezing of Gait in Parkinson's Disease

Conditions:   Parkinson's Disease;   Freezing of Gait
Intervention:   Drug: ATM FOG in PD
Sponsor:   Medical University of South Carolina
Completed
Wed, 29 Aug 2018 12:00:00 EDT

A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Guanfacine hydrochloride (TAK-503);   Drug: Atomoxetine hydrochloride;   Other: Placebo
Sponsors:   Shire;   Takeda Development Center Americas, Inc.
Recruiting
Wed, 11 Sep 2019 12:00:00 EDT

Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease

Conditions:   Depressive Disorder;   Parkinson Disease
Interventions:   Drug: Atomoxetine;   Drug: Placebo
Sponsors:   University of Pennsylvania;   National Institute of Mental Health (NIMH)
Completed
Fri, 17 Mar 2006 12:00:00 EST

Role of Coenzyme Q in ADHD in Children

Condition:   ADHD
Interventions:   Drug: Atomoxetine;   Drug: Coenzyme Q
Sponsor:   Sherief Abd-Elsalam
Recruiting
Thu, 02 Jan 2020 12:00:00 EST

Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach

Conditions:   Attention Deficit Hyperactivity Disorder;   ADHD
Interventions:   Other: fMRI scans;   Drug: Atomoxetine arm;   Drug: Methylphenidate arm
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Institute of Mental Health (NIMH)
Completed
Mon, 03 Sep 2012 12:00:00 EDT

Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine;   Drug: PNU-165442G; [S,S]-reboxetine
Sponsor:   Pfizer
Withdrawn
Wed, 21 Nov 2007 12:00:00 EST

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Atomoxetine;   Drug: Buspirone
Sponsor:   Pfizer
Completed
Thu, 15 Sep 2005 12:00:00 EDT

Crossover Trial of AD036 in Obstructive Sleep Apnea

Condition:   Obstructive Sleep Apnea
Interventions:   Drug: AD036;   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Apnimed
Completed
Wed, 24 Jun 2020 12:00:00 EDT

Atomoxetine to Treat Adolescents With Coexisting Alcohol and Other Substance Use Disorder and ADHD

Conditions:   Substance Use Disorders;   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Atomoxetine
Sponsors:   University of Pittsburgh;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed
Thu, 17 Jan 2002 12:00:00 EST

Unraveling the Nature of Impaired Pain Inhibition in Patients With Chronic Whiplash-associated Disorders

Condition:   Whiplash Injuries
Interventions:   Drug: Atomoxetine;   Drug: Citalopram
Sponsor:   Vrije Universiteit Brussel
Completed
Fri, 18 May 2012 12:00:00 EDT

Cognitive Decline in Non-demented PD

Condition:   Parkinson's Disease
Interventions:   Drug: Strattera;   Drug: Exelon;   Other: Placebo
Sponsors:   Oregon Health and Science University;   National Institute of Neurological Disorders and Stroke (NINDS)
Completed
Mon, 25 Apr 2011 12:00:00 EDT

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Methylphenidate;   Drug: Lisdexamfetamine;   Drug: Atomoxetine;   Drug: Amphetamine;   Drug: Dextroamphetamine
Sponsor:   Janssen Research & Development, LLC
Completed
Mon, 21 Oct 2019 12:00:00 EDT

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Extended-release Guanfacine Hydrochloride;   Drug: Atomoxetine Hydrochloride;   Drug: Placebo Comparator
Sponsor:   Shire
Completed
Fri, 19 Nov 2010 12:00:00 EST

Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: Strattera
Sponsor:   Norwegian University of Science and Technology
Completed
Tue, 25 Jul 2006 12:00:00 EDT

Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: Methylphenidate (MPH);   Drug: Atomoxetine
Sponsor:   Asan Medical Center
Unknown status
Thu, 30 Apr 2015 12:00:00 EDT

Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Conditions:   ADHD;   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate;   Drug: Atomoxetine
Sponsors:   Icahn School of Medicine at Mount Sinai;   National Institute on Drug Abuse (NIDA)
Recruiting
Thu, 20 Dec 2018 12:00:00 EST

Changes in Striatal [11C]ORM-13070 Binding Elicited by Changing Levels of Endogenous Noradrenaline

Condition:   Changes in Striatal [11C]ORM-13070 Binding.
Interventions:   Drug: Ketamine;   Drug: Atomoxetine;   Other: Cold pressor test;   Drug: Placebo
Sponsors:   University of Turku;   Turku University Hospital;   Orion Corporation, Orion Pharma
Completed
Wed, 20 Feb 2013 12:00:00 EST

EAA/Therapy for Treating Children With ADHD

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Behavioral: EAA/T;   Drug: Methylphenidate;   Drug: Atomoxetine
Sponsors:   Samsung Medical Center;   Samsung Electronics
Unknown status
Fri, 26 Jun 2015 12:00:00 EDT

A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors

Condition:   Attention-deficit Hyperactivity Disorder
Interventions:   Drug: Methylphenidate hydrochloride;   Drug: Atomoxetine
Sponsor:   Janssen Korea, Ltd., Korea
Completed
Thu, 21 Jun 2012 12:00:00 EDT

Autonomic Correlates of Impulsivity for Preschool Children With Attention Deficit Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: atomoxetine (or placebo)
Sponsor:   University of Arizona
Completed
Thu, 05 Mar 2009 12:00:00 EST

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

Conditions:   Neurofeedback;   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Behavioral: NIRS neurofeedback;   Drug: Methylphenidate or Tomoxetine
Sponsor:   Xijing Hospital
Unknown status
Thu, 22 Aug 2019 12:00:00 EDT

Agonist Replacement Therapy for Cocaine Dependence

Condition:   Cocaine Dependence
Intervention:   Drug: d-Amphetamine; Atomoxetine
Sponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA)
Completed
Fri, 13 Jun 2008 12:00:00 EDT

Parallel Arm Trial of AD109 and AD504 In Patients With OSA

Condition:   OSA - Obstructive Sleep Apnea
Interventions:   Drug: AD109;   Drug: AD504;   Drug: Atomoxetine Hydrochloride;   Drug: Placebo
Sponsor:   Apnimed
Not yet recruiting
Fri, 08 Oct 2021 12:00:00 EDT

The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults ADHD

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:  
Sponsor:   National Taiwan University Hospital
Completed
Wed, 10 Jun 2009 12:00:00 EDT

Atomoxetine Pilot Study in Preschool Children With ADHD

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: ATMX
Sponsor:   University of Arizona
Completed
Fri, 17 Aug 2007 12:00:00 EDT

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

Conditions:   Orthostatic; Hypotension, Neurogenic;   Autonomic Failure;   Pure Autonomic Failure;   Multiple System Atrophy;   Orthostatic; Hypotension, Parkinsonism
Interventions:   Device: Accelerometer;   Drug: placebo pill;   Drug: Midodrine or atomoxetine pill
Sponsor:   Vanderbilt University Medical Center
Recruiting
Thu, 04 Mar 2021 12:00:00 EST

Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients

Condition:   Schizophrenia
Interventions:   Behavioral: Diet support group;   Behavioral: Group counseling and exercise
Sponsors:   University of Maryland, Baltimore;   Eli Lilly and Company
Completed
Thu, 15 Sep 2005 12:00:00 EDT

Concerta Treatment in Adults With ADHD NOS

Condition:   ADHD NOS
Intervention:   Drug: atomoxetine (Strattera)
Sponsors:   Massachusetts General Hospital;   McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Completed
Fri, 16 Sep 2005 12:00:00 EDT

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Condition:   Adult Attention Deficit Hyperactivity Disorder
Interventions:   Drug: OPC-64005;   Drug: Atomoxetine;   Drug: Placebo
Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
Completed
Fri, 27 Oct 2017 12:00:00 EDT

Efficacy of Atomoxetine in the Neuropsychological Tests Among Children With ADHD

Condition:   Attention Deficit Disorder With Hyperactivity
Intervention:  
Sponsors:   National Taiwan University Hospital;   Eli Lilly and Company
Completed
Fri, 14 Sep 2007 12:00:00 EDT

A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention-Deficit/Hyperactivity Disorder
Interventions:   Drug: ABT-089;   Drug: atomoxetine;   Drug: placebo
Sponsor:   AbbVie (prior sponsor, Abbott)
Completed
Wed, 12 Sep 2007 12:00:00 EDT

Progesterone and Atomoxetine for Cocaine Cessation

Conditions:   Cocaine Dependence;   Nicotine Dependence
Interventions:   Drug: Progesterone;   Drug: Placebo
Sponsor:   University of Minnesota
Withdrawn
Tue, 04 Dec 2012 12:00:00 EST

The Effectiveness of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Drug: Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine;   Behavioral: Aerobic Exercise
Sponsor:   McGill University Health Centre/Research Institute of the McGill University Health Centre
Unknown status
Thu, 02 Jun 2016 12:00:00 EDT

ADHD Medication and Predictors of Treatment Outcome

Condition:   Attention Deficit Disorder With Hyperactivity (ADHD)
Interventions:   Drug: methylphenidate medication;   Drug: atomoxetine medication;   Drug: lisdexamphetamine medication;   Drug: guanfacine medication
Sponsor:   Karolinska Institutet
Active, not recruiting
Mon, 12 May 2014 12:00:00 EDT

A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Conditions:   Attention-Deficit/Hyperactivity Disorder;   ADHD
Interventions:   Drug: ABT-894;   Drug: atomoxetine;   Drug: placebo
Sponsor:   Abbott
Completed
Wed, 31 Jan 2007 12:00:00 EST

Crossover Trial of AD109 in Obstructive Sleep Apnea

Condition:   Obstructive Sleep Apnea
Interventions:   Drug: AD109;   Drug: Atomoxetine;   Drug: R-oxybutynin;   Drug: Placebo
Sponsor:   Apnimed
Completed
Thu, 08 Oct 2020 12:00:00 EDT

Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder

Conditions:   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Disorder;   Hyperkinetic Syndrome
Interventions:   Drug: methylphenidate;   Drug: Atomoxetine;   Behavioral: behavioral modification
Sponsors:   Far Eastern Memorial Hospital;   Academia Sinica, Taiwan;   National Taiwan University Hospital
Unknown status
Wed, 26 May 2010 12:00:00 EDT

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

Condition:   Attention Deficit Disorder With Hyperactivity
Interventions:   Drug: MPH (Concerta);   Drug: MPH (Ritalin);   Drug: Atomoxetine (ATO);   Drug: Guanfacine (GFC)
Sponsor:   Janssen Research & Development, LLC
Completed
Wed, 02 Oct 2019 12:00:00 EDT

Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline

Condition:   Healthy
Interventions:   Drug: Atipamezole;   Drug: Atomoxetine;   Drug: Ketamine;   Other: Cold pressor test;   Drug: Insulin;   Drug: Placebo
Sponsors:   University of Turku;   Orion Corporation, Orion Pharma
Completed
Fri, 16 Sep 2011 12:00:00 EDT

Interventions for Children With Attention and Reading Disorders

Conditions:   Attention Deficit Hyperactivity Disorder;   Reading Disabilities
Interventions:   Drug: Methylphenidate;   Behavioral: Intensive reading instruction;   Behavioral: Parent Training;   Drug: Mixed Salt Amphetamine;   Drug: Atomoxetine;   Drug: Guanfacine
Sponsors:   The University of Texas Health Science Center, Houston;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Children's Hospital Medical Center, Cincinnati
Completed
Mon, 31 May 2010 12:00:00 EDT

Therapeutic Drug Monitoring in Child and Adolescent Psychiatry

Conditions:   Depression;   Anorexia Nervosa;   ADHD
Interventions:   Drug: Atomoxetine;   Drug: Duloxetine;   Drug: Olanzapine;   Drug: Aripiprazole
Sponsor:   Medical University of Vienna
Completed
Wed, 27 Jan 2010 12:00:00 EST

Treatment of Orthostatic Hypotension in Autonomic Failure

Conditions:   Autonomic Failure;   Orthostatic Hypotension
Interventions:   Drug: Atomoxetine;   Drug: Acarbose;   Drug: Pyridostigmine Bromide;   Drug: Yohimbine;   Drug: Midodrine HCl;   Drug: placebo;   Drug: Modafinil;   Drug: Octreotide;   Other: water intake;   Drug: Diphenhydramine Hydrochloride;   Drug: Ranitidine HCL;   Drug: Tranylcypromine;   Drug: Ergotamine/ Caffeine;   Drug: Celecoxib;   Drug: Pseudoephedrine;   Drug: Methylphenidate;   Drug: Indomethacin;   Drug: Ibuprofen;   Drug: Oxymetazoline 0.05% nasal solution;   Dietary Supplement: Bovril;   Drug: Acetazolamide;   Drug: Rivastigmine tartrate;   Drug: Carbidopa/levodopa;   Device: Inflatable abdominal binder;   Device: inflatable abdominal binder (sham)
Sponsor:   Vanderbilt University
Completed
Thu, 22 Sep 2005 12:00:00 EDT

A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Atomoxetine 80 mg/d;   Drug: Placebo;   Drug: OROS methylphenidate HCl 54 mg/d;   Drug: JNJ-31001074 3 mg/d;   Drug: JNJ-31001074 1 mg/d;   Drug: JNJ-31001074 10 mg/d
Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed
Mon, 13 Apr 2009 12:00:00 EDT

The Reinforcing Mechanisms of Smoking in Adult ADHD

Condition:   ADHD
Interventions:   Drug: ADHD medication;   Drug: Placebo
Sponsor:   University of California, Irvine
Completed
Fri, 14 Dec 2007 12:00:00 EST

Treatment of Orthostatic Intolerance

Conditions:   Tachycardia;   Chronic Orthostatic Intolerance
Interventions:   Drug: Acetazolamide;   Drug: Atomoxetine;   Other: NO Drug;   Drug: Clonidine;   Drug: Entacapone;   Drug: Entacapone & Propranolol;   Drug: Atomoxetine & Propranolol;   Drug: Indomethacin;   Drug: Mecamylamine;   Drug: Isosorbide Dinitrate;   Dietary Supplement: Melatonin;   Drug: Midodrine;   Drug: Modafinil;   Drug: Octreotide;   Radiation: Placebo;   Drug: Propranolol;   Drug: Modafinil & Propranolol;   Drug: Sertraline;   Procedure: IV Saline;   Other: Drinking Water;   Device: Breathing Device;   Drug: memantine;   Device: Abdominal binder
Sponsors:   Satish R. Raj;   National Institutes of Health (NIH)
Active, not recruiting
Tue, 06 Dec 2005 12:00:00 EST

CBT Group for Adolescents With ADHD: a Randomized Controlled Trial

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Drug: Psychopharmacological treatment;   Behavioral: CBT group
Sponsor:   Hospital Universitari Vall d'Hebron Research Institute
Completed
Tue, 24 Jun 2014 12:00:00 EDT

Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:  
Sponsors:   National Taiwan University Hospital;   National Science Council, Taiwan
Completed
Wed, 10 Jun 2009 12:00:00 EDT

Norepinephrine Transporter Blockade, Autonomic Failure

Condition:   Multiple System Atrophy (MSA)
Interventions:   Drug: Atomexetine;   Drug: Placebo
Sponsors:   NYU Langone Health;   Vanderbilt University Medical Center
Recruiting
Fri, 10 Jun 2016 12:00:00 EDT

Treatment of Orthostatic Hypotension

Conditions:   Autonomic Nervous System Diseases;   Orthostatic Hypotension;   Dopamine Beta-Hydroxylase Deficiency;   Orthostatic Intolerance
Interventions:   Drug: droxidopa;   Drug: placebo;   Drug: alpha-methyldopa;   Drug: carbidopa;   Drug: metyrosine;   Drug: levodopa;   Drug: atomoxetine;   Drug: metoclopramide
Sponsor:   Vanderbilt University
Completed
Thu, 27 Dec 2007 12:00:00 EST

Treatment Drop-out and Missed Appointments Among Adults With ADHD

Conditions:   Attention-Deficit/Hyperactivity Disorder;   Drop-out;   Non-adherence
Intervention:   Other: Combined ADHD medication and psychosocial counseling
Sponsors:   University of Aarhus;   Central Denmark Region
Completed
Wed, 27 Aug 2014 12:00:00 EDT

Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism

Condition:   Major Depression
Intervention:   Other: Open label pharmacotherapy
Sponsor:   University of Ottawa
Completed
Wed, 25 Jun 2008 12:00:00 EDT

Effect of Probiotics on ADHD

Conditions:   ADHD;   Probiotics;   Gut Microbiota;   Psychiatry;   Clinical Trial
Interventions:   Drug: Placebo;   Other: BF688
Sponsor:   Wang Liang-Jen
Active, not recruiting
Mon, 12 Jul 2021 12:00:00 EDT

Effectiveness and Duration of Effect of Open Treatment in Attention Deficit Hyperactivity Disorder (ADHD) Patients Treated With Lisdexamfetamine Dimesylate(Vyvanse)

Condition:   Attention Deficit Hyperactivity Disorder
Intervention:   Drug: LDX Treatment
Sponsors:   NYU Langone Health;   Shire
Completed
Thu, 18 Feb 2010 12:00:00 EST

Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)

Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Interventions:   Behavioral: Academic and Organization skills;   Behavioral: Parent Training;   Behavioral: Social Skills Training;   Drug: Long-acting stimulant
Sponsors:   McGill University Health Centre/Research Institute of the McGill University Health Centre;   Canadian Institutes of Health Research (CIHR)
Unknown status
Tue, 20 May 2014 12:00:00 EDT

Omega-3 Fatty Acid Supplementation to ADHD Pharmacotherapy in ADHD Adults With Deficient Emotional Self-Regulation Traits

Conditions:   Attention Deficit Hyperactivity Disorder (ADHD);   Deficient Emotional Self-Regulation (DESR)
Interventions:   Drug: ADHD Medication;   Drug: Omega-3 Fatty Acids
Sponsor:   Massachusetts General Hospital
Completed
Fri, 22 Jul 2011 12:00:00 EDT

Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Other: MYmind mindfulness training;   Other: Care-as-usual for children (8-16 years old) with ADHD
Sponsors:   Karakter Kinder- en Jeugdpsychiatrie;   Fonds Psychische Gezondheid;   European Commission;   UvA minds;   Radboud University;   University of Amsterdam
Completed
Tue, 18 Jul 2017 12:00:00 EDT

A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

Condition:   Adverse Drug Reaction
Intervention:   Other: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
Sponsors:   Indiana University;   National Human Genome Research Institute (NHGRI)
Completed
Fri, 21 Nov 2014 12:00:00 EST

Study of the Effect of Calorie Supplementation on Growth in Young Children on ADHD Medication

Condition:   ADHD
Interventions:   Dietary Supplement: Pediasure;   Behavioral: Nutritional counseling
Sponsor:   University of Nebraska
Completed
Tue, 20 Nov 2007 12:00:00 EST

Effectiveness of a Mobile Neurofeedback for ADHD Youth

Condition:   Attention Deficit Hyperactivity Disorder
Interventions:   Device: mobile neurofeedback;   Device: Sham mobile neurofeedback;   Device: medication + mobile neurofeedback;   Device: medication + Sham mobile neurofeedback
Sponsors:   Seoul National University Childrens Hospital;   Hanyang University;   Wonkwang University Hospital
Recruiting
Tue, 14 Jul 2020 12:00:00 EDT

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

Condition:   Attention Deficit Hyperactivity Disorder (ADHD)
Intervention:  
Sponsors:   NHS Tayside;   Zentralinstitut für Seelische Gesundheit Mannheim;   Universita degli Studi di Cagliari;   Vadaskert Child and Adolescent Psychiatric Hospital
Completed
Fri, 11 Nov 2011 12:00:00 EST

YouScript IMPACT Registry

Conditions:   Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention:  
Sponsors:   Genelex Corporation;   University of Utah
Completed
Wed, 16 Jul 2014 12:00:00 EDT